Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1

Cancer Cell

Volumn 2, Issue 6, 2002, Pages 473-483

  Volpert, Olga V ^b   Pili, Roberto ^a   Sikder, Hashmat A ^a   Nelius, Thomas ^b   Zaichuk, Tetiana ^b   Morris, Chad ^a   Shiflett, Clinton B ^a   Devlin, Meghann K ^a   Conant, Katherine ^c   Alani, Rhoda M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 1; NEUTRALIZING ANTIBODY; NUCLEIC ACID BINDING PROTEIN; THROMBOSPONDIN 1; THROMBOSPONDIN 1 NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; ID1 PROTEIN, HUMAN; IDB1 PROTEIN, MOUSE; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; EMBRYO; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NULL ALLELE; PRIORITY JOURNAL; PROTEIN TARGETING; SPECIES COMPARISON; TRANSCRIPTION REGULATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CATTLE; CELL CULTURE; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; E BOX ELEMENT; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELL MOVEMENT; CELLS, CULTURED; E-BOX ELEMENTS; EMBRYO; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; THROMBOSPONDIN 1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 19044388761     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00209-X     Document Type: Article

References (45)

1. Alani, R.M., Young, A.Z., and Shifflett, C.B. (2001). Id1 regulation of cellular senescence through transcriptional repression of p16/lnk4a. Proc. Natl. Acad. Sci. USA 98, 7812-7816.
2. Benezra, R., Rafii, S., and Lyden, D. (2001). The Id proteins and angiogenesis. Oncogene 20, 8334-8341.
3. Benjamin, L.E. (2000). The controls of microvascular survival. Cancer Metastasis Rev. 19, 75-81.
4. Bleuel, K., Popp, S., Fusenig, N.E., Stanbridge, E.J., and Boukamp, P. (1999). Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc. Natl. Acad. Sci. USA 96, 2065-2070.
5. Bornstein, P., Alfi, D., Devarayalu, S., Framson, P., and Li, P. (1990). Characterization of the mouse thrombospondin gene and evaluation of the role of the first intron in human gene expression. J. Biol. Chem. 265, 16691-16698.
6. Bouck, N., Stellmach, V., and Hsu, S.C. (1996). How tumors become angiogenic. Adv. Cancer Res. 69, 135-174.
7. Dameron, K.M., Volpert, O.V., Tainsky, M.A., and Bouck, N. (1994). Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584.
8. Dejong, V., Degeorges, A., Filleur, S., Ait-Si-Ali, S., Mettouchi, A., Bornstein, P., Binetruy, B., and Cabon, F. (1999). The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun. Oncogene 18, 3143-3151.
9. Folkman, J. (1995). Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757-1763.
10. Folkman, J., and Klagsbrun, M. (1987). Angiogenic factors. Science 235, 442-447.
11. Good, D.J., Polverini, P.J., Rastinejad, F., Le Beau, M.M., Lemons, R.S., Frazier, W.A., and Bouck, N.P. (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624-6628.
12. Guo, N., Krutzsch, H.C., Inman, J.K., and Roberts, D.D. (1997). Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res. 57, 1735-1742.
13. Hanahan, D., and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
14. Jacobs, J.J., Kieboom, K., Marino, S., DePinho, R.A., and van Lohuizen, M. (1999). The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168.
15. Jimenez, B., Volpert, O.V., Crawford, S.E., Febbraio, M., Silverstein, R.L., and Bouck, N. (2000). Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6, 41-48.
16. Klagsbrun, M., and D'Amore, P.A. (1991). Regulators of angiogenesis. Annu. Rev. Physiol. 53, 217-239.
17. Kuzu, I., Bicknell, R., Fletcher, C.D., and Gatter, K.C. (1993). Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab. Invest. 69, 322-328.
18. Lasorella, A., Uo, T., and Iavarone, A. (2001). Id proteins at the cross-road of development and cancer. Oncogene 20, 8326-8333.
19. Lawler, J., Miao, W.M., Duquette, M., Bouck, N., Bronson, R.T., and Hynes, R.O. (2001). Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice. Am. J. Pathol. 159, 1949-1956.
20. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001). Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201.
21. Lyden, D., Young, A.Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R., Bader, B.L., Hynes, R.O., Zhuang, Y., Manova, K., and Benezra, R. (1999). Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670-677.
22. Massari, M.E., and Murre, C. (2000). Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20, 429-440.
23. Mettouchi, A., Cabon, F., Montreau, N., Vernier, P., Mercier, G., Blangy, D., Tricoire, H., Vigier, P., and Binetruy, B. (1994). SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts. EMBO J. 13, 5668-5678.
24. Norton, J.D. (2000). ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113, 3897-3905.
25. Passaniti, A., Taylor, R.M., Pili, R., Guo, Y., Long, P.V., Haney, J.A., Pauly, R.R., Grant, D.S., and Martin, G.R. (1992). A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528.
26. Polverini, P. J., Bouck, N.P., and Rastinejad, F. (1991). Assay and purification of naturally occurring inhibitor of angiogenesis. Methods Enzymol. 198, 440-450.
27. Rak, J., Mitsuhashi, Y., Sheehan, C., Tamir, A., Viloria-Petit, A., Filmus, J., Mansour, S.J., Ahn, N.G., and Kerbel, R.S. (2000). Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res. 60, 490-498.
28. Regezi, J.A., Macphail, L.A., Richards, D.W., and Greenspan, J.S. (1993). A study of macrophages, macrophage-related cells, and endothelial adhesion molecules in recurrent aphthous ulcers in HIV-positive patients. J. Dent. Res. 72, 1549-1553.
29. Reynolds, L.E., Wyder, L., Lively, J.C., Taverna, D., Robinson, S.D., Huang, X., Sheppard, D., Hynes, R.O., and Hodivala-Dilke, K.M. (2002). Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat. Med. 8, 27-34.
30. Rivera, R., and Murre, C. (2001). The regulation and function of the Id proteins in lymphocyte development. Oncogene 20, 8308-8316.
31. Rodriguez-Manzaneque, J.C., Lane, T.F., Ortega, M.A., Hynes, R.O., Lawler, J., and Iruela-Arispe, M.L. (2001). Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA 98, 12485-12490.
32. Sheibani, N., and Frazier, W.A. (1995). Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc. Natl. Acad. Sci. USA 92, 6788-6792.
33. Shingu, T., and Bornstein, P. (1994). Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene. J. Biol. Chem. 269, 32551-32557.
34. Slack, J.L., and Bornstein, P. (1994). Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1. Cell Growth Differ. 5, 1373-1380.
35. Stellmach, V., Volpert, O.V., Crawford, S.E., Lawler, J., Hynes, R.O., and Bouck, N. (1996). Tumour suppressor genes and angiogenesis: the role of TP53 in fibroblasts. Eur. J. Cancer 32A, 2394-2400.
36. Streit, M., Velasco, P., Brown, L.F., Skobe, M., Richard, L., Riccardi, L., Lawler, J., and Detmar, M. (1999). Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am. J. Pathol. 155, 441-452.
37. Streit, M., Velasco, P., Riccardi, L., Spencer, L., Brown, L.F., Janes, L., Lange-Asschenfeldt, B., Yano, K., Hawighorst, T., Iruela-Arispe, L., and Detmar, M. (2000). Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J. 19, 3272-3282.
38. Tikhonenko, A.T., Black, D.J., and Linial, M.L. (1996). Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J. Biol. Chem. 271, 30741-30747.
39. Volpert, O.V., Lawler, J., and Bouck, N.P. (1998). A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc. Natl. Acad. Sci. USA 95, 6343-6348.
40. Volpert, O.V., Zaichuk, T., Zhou, W., Reiher, F., Ferguson, T.A., Stuart, P.M., Amin, M., and Bouck, N.P. (2002). Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat. Med. 8, 349-357.
41. Weinstat-Saslow, D.L., Zabrenetzky, V.S., VanHoutte, K., Frazier, W.A., Roberts, D.D., and Steeg, P.S. (1994). Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 54, 6504-6511.
42. Wen, S., Stolarov, J., Myers, M.P., Su, J.D., Wigler, M.H., Tonks, N.K., and Durden, D.L. (2001). PTEN controls tumor-induced angiogenesis. Proc. Natl. Acad. Sci. USA 98, 4622-4627.
43. Yan, W., Young, A.Z., Soares, V.C., Kelley, R., Benezra, R., and Zhuang, Y. (1997). High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17, 7317-7327.
44. Zabrenetzky, V., Harris, C.C., Steeg, P.S., and Roberts, D.D. (1994). Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int. J. Cancer 59, 191-195.
45. Zebedee, Z., and Hara, E. (2001). Id proteins in cell cycle control and cellular senescence. Oncogene 20, 8317-8325.